Inhaled prostacyclin therapy in the acute respiratory distress syndrome: a randomized controlled multicenter trial

BACKGROUND: Acute respiratory distress syndrome (ARDS) results in significant hypoxia, and ARDS is the central pathology of COVID-19. Inhaled prostacyclin has been proposed as a therapy for ARDS, but data regarding its role in this syndrome are unavailable. Therefore, we investigated whether inhaled...

Descripción completa

Detalles Bibliográficos
Autores principales: Haeberle, Helene A., Calov, Stefanie, Martus, Peter, Serna-Higuita, Lina Maria, Koeppen, Michael, Goll, Almuth, Bernard, Alice, Zarbock, Alexander, Meersch, Melanie, Weiss, Raphael, Mehrländer, Martin, Marx, Gernot, Putensen, Christian, Bakchoul, Tamam, Magunia, Harry, Nieswandt, Bernhard, Mirakaj, Valbona, Rosenberger, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9938510/
https://www.ncbi.nlm.nih.gov/pubmed/36805707
http://dx.doi.org/10.1186/s12931-023-02346-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9938510/
https://www.ncbi.nlm.nih.gov/pubmed/36805707
http://dx.doi.org/10.1186/s12931-023-02346-0

Ejemplares similares